Rexulti Works for Agitation in Alzheimer's, Despite Risks, Says FDA Staff

Increased mortality risk consistent with other antipsychotics in elderly dementia patients

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for Agitation - Mad In America

STOP Treating Behaviors with Restraining Medications - Positive Approach to Care

Rexukti has been FDA aporoved to treat agitation in dementia but it in, Dementia

Not Everyone Agreed With FDA Approval of Antipsychotic Rexulti for Agitation - Mad In America

Alzheimer's drug controversies and scandals: behind closed doors

Brexpiprazole (Rexulti) Approved for Alzheimer's Agitation

Rexulti Approved for Agitation Associated With Dementia Due to Alzheimer Disease

FDA Approves Rexulti for Agitation Associated With Dementia Due to Alzheimer's Disease

Dementia Treatment: An Unmet Need

FDA fast-tracks drug for dementia agitation that increases risk of death 4 times - Study Finds

SLU Researcher Finds Help for Alzheimer's-Associated Agitation with New FDA-Approved Treatment : SLU

FDA Approves First Drug for Treating Agitation in Alzheimer's Patients - MedCity News